132 related articles for article (PubMed ID: 9497103)
1. Differential regulation of the human 'leukemia inhibitory factor' (LIF) promoter in T47D and MDA-MB 231 breast cancer cells.
Bamberger AM; Thuneke I; Schulte HM
Breast Cancer Res Treat; 1998 Jan; 47(2):153-61. PubMed ID: 9497103
[TBL] [Abstract][Full Text] [Related]
2. Progestin-dependent stimulation of the human leukemia inhibitory factor promoter in SKUT-1B uterine tumor cells.
Bamberger AM; Jenatschke S; Erdmann I; Schulte HM
J Reprod Immunol; 1997 Jul; 33(3):189-201. PubMed ID: 9255723
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the human 'leukemia inhibitory factor' gene: modulation by glucocorticoids and estradiol.
Bamberger AM; Erdmann I; Bamberger CM; Jenatschke SS; Schulte HM
Mol Cell Endocrinol; 1997 Mar; 127(1):71-9. PubMed ID: 9099902
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the human leukaemia inhibitory factor (LIF) promoter in HEC-1B endometrial adenocarcinoma cells.
Bamberger AM; Erdmann I; Jenatschke S; Bamberger CM; Schulte HM
Mol Hum Reprod; 1997 Sep; 3(9):789-93. PubMed ID: 9358005
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
6. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
7. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773
[TBL] [Abstract][Full Text] [Related]
8. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
9. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lakins J; Lupu R
Oncol Rep; 2000; 7(1):157-67. PubMed ID: 10601611
[TBL] [Abstract][Full Text] [Related]
10. Estradiol regulation of the human retinoic acid receptor alpha gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs.
Rishi AK; Shao ZM; Baumann RG; Li XS; Sheikh MS; Kimura S; Bashirelahi N; Fontana JA
Cancer Res; 1995 Nov; 55(21):4999-5006. PubMed ID: 7585542
[TBL] [Abstract][Full Text] [Related]
11. Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines.
Castronovo V; Taraboletti G; Liotta LA; Sobel ME
J Natl Cancer Inst; 1989 May; 81(10):781-8. PubMed ID: 2523976
[TBL] [Abstract][Full Text] [Related]
12. Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG3 choriocarcinoma cells.
Bamberger AM; Jenatschke S; Schulte HM; Löning T; Bamberger MC
J Clin Endocrinol Metab; 2000 Oct; 85(10):3932-6. PubMed ID: 11061559
[TBL] [Abstract][Full Text] [Related]
13. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
[TBL] [Abstract][Full Text] [Related]
14. Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways.
Kellokumpu-Lehtinen P; Talpaz M; Harris D; Van Q; Kurzrock R; Estrov Z
Int J Cancer; 1996 May; 66(4):515-9. PubMed ID: 8635867
[TBL] [Abstract][Full Text] [Related]
15. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
Lu M; Mira-y-Lopez R; Nakajo S; Nakaya K; Jing Y
Oncogene; 2005 Jun; 24(27):4362-9. PubMed ID: 15870697
[TBL] [Abstract][Full Text] [Related]
16. Studies on the relationship between estrogen receptor content, glutathione S-transferase pi expression, and induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and drug resistance in human breast cancer cells.
Hoivik D; Wilson C; Wang W; Willett K; Barhoumi R; Burghardt R; Safe S
Arch Biochem Biophys; 1997 Dec; 348(1):174-82. PubMed ID: 9390189
[TBL] [Abstract][Full Text] [Related]
17. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder SM; Murthy L; Stancel GM
Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
[TBL] [Abstract][Full Text] [Related]
18. Regulatory elements of the leukaemia inhibitory factor (LIF) promoter in murine bone marrow stromal cells.
Göllner G; Bug G; Rupilius B; Peschel C; Huber C; Derigs HG
Cytokine; 1999 Sep; 11(9):656-63. PubMed ID: 10479401
[TBL] [Abstract][Full Text] [Related]
19. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
Lin Y; Wang SM; Huang RP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
[TBL] [Abstract][Full Text] [Related]
20. Progestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells.
Novellasdemunt L; Obach M; Millán-Ariño L; Manzano A; Ventura F; Rosa JL; Jordan A; Navarro-Sabate A; Bartrons R
Biochem J; 2012 Mar; 442(2):345-56. PubMed ID: 22115192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
